Elevated pulmonary vascular resistance (PVR) is a contraindication to cardiac transplantation (OHT). Bridge-to-transplant (BTT) with left ventricular assist device (LVAD) may reduce PVR though its efficacy and long-term outcomes are unknown.
Extra-corporeal membrane oxygenation (ECMO) as a bridge to left ventricular assist device (LVAD) implantation has been adopted as a strategy to improve end-organ function and optimize outcomes, though the practice remains controversial.